This grant offered by the Department of Defense supports clinical trials aiming to impact the treatment or management of Autism Spectrum Disorder. Funds cannot be used for preclinical studies. The grant prioritizes addressing co-morbidity and predictors for treatment outcomes within the autism community. Applications targeting manifestations, predictors for treatment responses, and effects on intellectual ability are encouraged. Clinical trials must commence within 12 months post-award. The closing date for applications is August 19, 2009, 12:00:00 AM EDT.
Opportunity ID: 45102
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-ARP-CTA |
| Funding Opportunity Title: | DoD Autism Research Program Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Feb 01, 2009 |
| Last Updated Date: | Jun 18, 2009 |
| Original Closing Date for Applications: | Jul 22, 2009 |
| Current Closing Date for Applications: | Aug 19, 2009 |
| Archive Date: | Aug 21, 2009 |
| Estimated Total Program Funding: | $2,200,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The ARP CTA supports clinical trials with the potential to have a major impact on the treatment or management of ASD. Funding from this award mechanism cannot be used for preclinical research studies. Refer to the Application Instructions and General Information, Appendix 6, for helpful information about distinguishing clinical trials and clinical research. The proposed clinical trial is expected to begin no later than 12 months after the award date. Areas of Interest (Revised for FY09): The FY09 ARP encourages applications that address critical needs of the autism community in the following areas: Co-morbidity: (e.g., manifestations such as disorders [gastrointestinal, sleep, behavioral, speech/language], psychiatric, seizures, immune dysfunction, motor and sensory deficits, metabolic dysfunction, and effects of ASD on intellectual ability) Predictors for Treatment Outcome: Identification of biomarkers, clinical characteristics, or other phenotypic markers that predict outcomes of a treatment (traditional or complementary and alternative), or populations that will or will not respond to a treatment. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Application Submission Deadline is changed to August 19, 2009. | Jun 18, 2009 | |
| Jun 18, 2009 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-ARP-CTA |
| Funding Opportunity Title: | DoD Autism Research Program Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Feb 01, 2009 |
| Last Updated Date: | Jun 18, 2009 |
| Original Closing Date for Applications: | Jul 22, 2009 |
| Current Closing Date for Applications: | Aug 19, 2009 |
| Archive Date: | Aug 21, 2009 |
| Estimated Total Program Funding: | $2,200,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The ARP CTA supports clinical trials with the potential to have a major impact on the treatment or management of ASD. Funding from this award mechanism cannot be used for preclinical research studies. Refer to the Application Instructions and General Information, Appendix 6, for helpful information about distinguishing clinical trials and clinical research. The proposed clinical trial is expected to begin no later than 12 months after the award date. Areas of Interest (Revised for FY09): The FY09 ARP encourages applications that address critical needs of the autism community in the following areas: Co-morbidity: (e.g., manifestations such as disorders [gastrointestinal, sleep, behavioral, speech/language], psychiatric, seizures, immune dysfunction, motor and sensory deficits, metabolic dysfunction, and effects of ASD on intellectual ability) Predictors for Treatment Outcome: Identification of biomarkers, clinical characteristics, or other phenotypic markers that predict outcomes of a treatment (traditional or complementary and alternative), or populations that will or will not respond to a treatment. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-ARP-CTA |
| Funding Opportunity Title: | DoD Autism Research Program Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 18, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jul 22, 2009 |
| Archive Date: | Aug 21, 2009 |
| Estimated Total Program Funding: | $2,200,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The ARP CTA supports clinical trials with the potential to have a major impact on the treatment or management of ASD. Funding from this award mechanism cannot be used for preclinical research studies. Refer to the Application Instructions and General Information, Appendix 6, for helpful information about distinguishing clinical trials and clinical research. The proposed clinical trial is expected to begin no later than 12 months after the award date. Areas of Interest (Revised for FY09): The FY09 ARP encourages applications that address critical needs of the autism community in the following areas: Co-morbidity: (e.g., manifestations such as disorders [gastrointestinal, sleep, behavioral, speech/language], psychiatric, seizures, immune dysfunction, motor and sensory deficits, metabolic dysfunction, and effects of ASD on intellectual ability) Predictors for Treatment Outcome: Identification of biomarkers, clinical characteristics, or other phenotypic markers that predict outcomes of a treatment (traditional or complementary and alternative), or populations that will or will not respond to a treatment. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
Related Documents
Folder 45102 Full Announcement-1 -> biosketch.pdf
Folder 45102 Full Announcement-1 -> ARP09 CTA_PA EDITED FINAL.pdf
Folder 45102 Full Announcement-1 -> Budget Form Reader.pdf
Folder 45102 Revised Full Announcement-1 -> arp09 cta_pa_edited final.pdf
Packages
| Agency Contact Information: | PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org Email: cdmrp.pa@amedd.army.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00010273 | Feb 01, 2009 | Aug 19, 2009 | View |
Package 1
Mandatory forms
45102 RR_SF424-1.1.pdf
45102 RR_PerformanceSite-1.1.pdf
45102 RR_KeyPersonExpanded-1.1.pdf
Leave a Reply